Dr. Jeff Tosoian
Urologic Oncologist
1 Podcast on BackTable
Dr. Jeffrey Tosoian is an assistant professor of urology and the director of translational cancer research with Vanderbilt in Nashville, Tennessee.
Learn from the experiences and expertise of Dr. Jeff Tosoian and other leading voices in your specialty on the BackTable app.
Episode # 172 • 18 Jun 2024
Advancing Cancer Care: AUA 2024 Highlights in Prostate & Bladder Cancer
In this episode of the BackTable Urology, Dr. Bogdana Schmidt (University of Utah), Dr. Woodson Smelser (Washington University in St. Louis), and Dr. Jeff Tosoian (Vanderbilt University) discusses the latest insights and advancements in prostate and bladder cancer treatment presented at AUA 2024.
This podcast is supported by
More from Dr. Jeff Tosoian
About
Dr. Tosoian specializes in the early diagnosis and management of urologic cancers. In addition to his role as a clinician and surgeon, he is a recognized leader in clinical and translational prostate cancer research. His early research demonstrated the safety of monitoring lower-risk prostate cancers on active surveillance, allowing appropriately selected patients to delay or avoid treatment altogether. His ongoing research has led to the development of new, non-invasive tools to guide cancer diagnosis and management. Dr. Tosoian leads the Prostate Cancer Risk Clinic, a clinical program for informed early screening in patients with a strong family history or known genetic mutation associated with prostate cancer.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.